NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-217-2007-0-JP-09 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP DIV 2014-208695 Issued
NCI E-025-2006-0-US-03 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use US National Stage 12/095,697 8088729 Issued PDF
NCI E-164-2007-0-PCT-02 PEPTIDE-BASED STAT INHIBITOR PCT PCT PCT/US2008/065352 Expired
NHGRI E-217-2007-0-PCT-02 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT PCT PCT PCT/US2008/006895 Expired
NHGRI E-217-2007-0-EP-04 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT EP National Stage 08767999.9 Abandoned
NHGRI E-217-2007-0-JP-06 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP National Stage 2010-510363 Abandoned
NIAID E-218-2008-0-US-01 A High-Throughput Screen For T-Lymphocyte Antigens Using Proteins Expressed By In-Vitro Transcription By Translation And Coupled To Latex Heads US 61/056,359 Abandoned
NHLBI E-120-2003-2-US-02 METHOD OF INDUCING MEMORY B CELL DEVELOPMENT AND TERMINAL DIFFERENTIATION US DIV 12/126,166 8247228 Abandoned PDF
NCI E-279-2005-0-US-06 Poly-saccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates US National Stage 12/092,184 7928079 Issued PDF
NIAID E-115-2000-0-CN-26 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines CN DIV 200810098526.2 Abandoned
CC E-063-2008-0-US-01 DENDRITIC CONJUGATES AND METHODS OF USE US 61/055,328 Abandoned
NIDDK E-324-2004-3-US-02 In Vitro Model For Hepatitis C Virion Production US National Stage 11/664,375 Abandoned
NCI E-182-2008-0-US-01 METHOD OF TREATING PNEUMOCONIOSIS WITH OLIGODEOXYNUCLEOTIDES US 61/055,102 Abandoned
NIAID E-174-2007-0-PCT-02 SUPPRESSION OF ALLERGIC INFLAMMATION BY ASCARIS HEME-BINDING PROTEINS PCT PCT PCT/US2008/006367 Expired
NIAID E-174-2007-0-US-03 Suppression Of Allergic Inflammation By Ascaris Heme-Binding Protein (HBP) US National Stage 12/600,363 Abandoned
NCI E-316-2008-0-US-01 Methods And Systems Using Therapeutic, Diagnostic or Prophylactic Magnetic Agents US 61/054,239 Abandoned
NIAID E-171-2007-2-PCT-01 Adaptive Mutations That Increase The Infectivity Of Hepatitis C Virus JFH1 In Cell Culture PCT PCT COMB PCT/US2008/063982 Abandoned
NIAID E-343-2008-0-US-02 Long-lasting Inhibitors Of Viral Infection US ORD 12/122,643 Abandoned
NCI E-091-2008-0-US-01 METHOD FOR DETECTION AND QUANTIFICATION OF PLK1 EXPRESSION AND ACTIVITY US 61/054,032 Abandoned
NIDCR E-015-2002-1-US-04 Mammalians Sweet And Amino Acid Heterodimeric Taste receptors Comprising T1R3 And T1R1 US CON 12/121,576 7842786 Expired PDF
NCI E-070-2008-0-US-01 BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF US ORD 12/121,208 Abandoned
NCI E-244-1997-3-US-07 Vacuolar-Type (H+)-ATPase-Inhibiting Compounds,and Uses Thereof US DIV 12/120,778 Abandoned
NCI E-262-2008-0-US-01 APOGOSSYPOL ATROPOISOMERS AND METHODS OF PREPARING THEREOF US 61/053,521 Abandoned
NCI E-258-2008-0-US-01 Design And Synthesis Of Aromatecin Derivatives And Their Identification As Topoisomerase 1 Inhibitors And Anti-cancer Agents65107.00.WO US 61/053,338 Abandoned
NCI E-204-2007-0-PCT-02 METHODS OF GLYCOSYLATION AND BIOCONJUGATION PCT PCT PCT/US2008/006248 Expired
NCI E-103-2005-3-US-02 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US ORD 11/883,495 8404244 Issued PDF
NCI E-192-2008-1-US-01 Optimization Of Expression Of Multimeric Proteins US 61/052,916 Abandoned
NCI E-029-2006-1-US-06 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF US National Stage 12/093,398 8053443 Issued PDF
NIMH E-155-2008-0-US-01 RADIOTRACERS FOR IMAGING CANNABINOID SUB-TYPE 1 (CB1) RECEPTOR US 61/052,581 Abandoned
NCI E-192-2008-0-US-01 OPTIMIZATION OF EXPRESSION OF HETERODIMERS US 61/052,239 Abandoned
NCI E-019-2006-0-US-07 Materials and Methods For ABCB1 Polymorphic Variant Screening, Diagnosis, and Treatment US National Stage 12/093,225 Abandoned
NIAID E-239-2007-2-EP-02 PSM PEPTIDES AS VACCINE TARGETS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS EP National Stage 08755197.4 Issued
NIAID E-239-2007-2-GB-05 PSM PEPTIDES AS VACCINE TARGETS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS GB EP 08755197.4 Issued
NIAID E-239-2007-2-FR-04 PSM PEPTIDES AS VACCINE TARGETS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS FR EP 08755197.4 Issued
NIAID E-239-2007-2-DE-03 PSM PEPTIDES AS VACCINE TARGETS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DE EP 08755197.4 Issued
NIAID E-045-2007-1-DE-05 Human Parainfluenza Viruses Having Separated P and C Genes DE EP 08780603.0 Abandoned
NIAID E-045-2007-1-FR-06 Human Parainfluenza Viruses Having Separated P and C Genes FR EP 08780603.0 Abandoned
NIAID E-045-2007-1-CH-04 Human Parainfluenza Viruses Having Separated P and C Genes CH EP 08780603.0 Abandoned
NIAID E-045-2007-1-GB-07 Human Parainfluenza Viruses Having Separated P and C Genes GB EP 08780603.0 Abandoned
NIAID E-045-2007-1-EP-02 Human Parainfluenza Viruses Having Separated P and C Genes EP National Stage 08780603.0 Abandoned
NCI E-261-2005-2-US-02 Method For Diagnosing And Monitoring The Progression Of Cancer US National Stage 12/093,012 7964365 Issued PDF
NIAID E-045-2007-1-PCT-01 The Overlapping Reading Frames Of The P/C Gene Of HPIV1 Have Been Separated To Generate A Recombinant HPIV1 (rHPIV1) Expressing The P And C Proteins From Separate Genes. PCT PCT COMB PCT/US2008/063033 Expired
NIAID E-239-2007-2-PCT-01 PSM PEPTIDES AS VACCINE TARGETS AGAINST COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS PCT PCT COMB PCT/US2008/063119 Expired
NIAID E-189-2008-0-US-01 LJL143 AND LJM17 FROM LUTZOMIA LONGIPALPIS THAT ELICIT CELLULAR IMMUNITY TO LEISHMANIA INFATUM CHAGASI PARASITES US 61/051,635 Abandoned
NCI E-339-2004-0-US-03 Framework Residue Substituted Humanized Col-1 Antibodies and their Use US National Stage 11/813,092 7855276 Abandoned PDF
NHLBI E-183-2004-1-US-06 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS US National Stage 11/718,387 Abandoned
NIAID E-043-2006-3-US-02 NON-VIRAL GENE DELIVERY COMPLEX US National Stage 12/092,811 Abandoned
NCI E-072-2008-0-US-01 HIV IMMUNOGEN AND METHOD OF MAKING AND USING SAME US 61/126,662 Abandoned
NICHD E-079-2003-1-US-01 Non-Invasive In Vivo, MRI Axon Diameter Measurement Methods US CIP 12/114,713 8380280 Abandoned PDF
NCI E-312-2005-0-US-03 A Peptide Epitope And Improvement Thereof Inducing T Cell Immunity To Alveolar Rhabdomyosarcoma In HLA-B7-Posiitve Individuals US National Stage 12/092,449 7867977 Abandoned PDF